Work

Poster: ALL-424 Updated Results from the Phase II Study of Blinatumomab in Combination With Ponatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Year: 2022

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(22)00705-4

Authors: Fadi G. Haddad, Hagop Kantarjian, Nicholas J. Short, Marina Konopleva, Nitin Jain, Xuelin Huang, Farhad Ravandi, William Wierda, Gautam Borthakur, Koji Sasaki, Ghayas Issa, Yesid Alvarado, Naveen Pemmaraju, Guillermo Garcia-Manero, Jennifer Thankachan, Rebecca Garris, Elias Jabbour

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4296532741

FWCI:

Cites:

Cited by:

Related to: 10